Dr. Dienstmann provides a significant strategic advantage to the cohort by combining a PhD in molecular diagnostic efficiency with an MBA from ESADE. This dual background allows him to bridge the gap between clinical efficacy and system sustainability, ensuring the economic viability and scaling of precision medicine programs.

Academic Titles & Degrees: MD; PhD in Molecular Diagnostic Program Efficiency (University of Vic); MBA (ESADE Business School).

Current Executive & Clinical Appointments:  Principal Investigator of the Oncology Data Science Group at VHIO (Spain); Medical Director of the Precision Medicine and Big Data Laboratory at Oncoclínicas & Co; Editor-in-Chief of ESMO Real World Data and Digital Oncology.

Research Axes & Leadership: Strategic implementation of molecular diagnostic programs; former research fellow at Massachusetts General Hospital (Boston) and VHIO.

High-Impact Publications & Awards: Over 200 publications in peer-reviewed journals, including editorial leadership at ESMO Open.